Categories
Divergent News Healthcare & Wellness

FDA review finds no increased risk of prostate cancer with Parkinson’s disease medicines containing entacapone (Comtan, Stalevo) | FDA

FDA Drug Safety Communication

Source: FDA review finds no increased risk of prostate cancer with Parkinson’s disease medicines containing entacapone (Comtan, Stalevo) | FDA


By International Badass Activists

Contact | internationalbadassactivists@gmail.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.